CRAI trades 1.9% above Wall Street's consensus target of $194.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CRAI achieves its forward estimates and maintains a stable P/E multiple of 24.0x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, CRA International, Inc. (CRAI) has a Wall Street consensus price target of $194.00, based on estimates from 1 covering analysts. With the stock currently trading at $197.66, this represents a potential downside of -1.9%. The company has a market capitalization of $1.28B.
Analyst price targets range from a low of $194.00 to a high of $194.00, representing a 0% spread in expectations. The median target of $194.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CRAI trades at a trailing P/E of 24.2x and forward P/E of 24.0x. The forward PEG ratio of 1.11 indicates reasonable valuation for growth. Analysts expect EPS to grow +7.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $246.56, with bear and bull scenarios of $155.33 and $324.87 respectively. Model confidence stands at 51/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HURNHuron Consulting Group Inc. | $2.7B | $166.82 | $216.50 | +29.8% | Buy | 18.0x | 9 |
 FTITechnipFMC plc | $25.3B | $63.52 | $87.50 | +37.8% | Buy | 19.8x | 50 |
 EXPOExponent, Inc. | $4.1B | $84.02 | $72.00 | -14.3% | Buy | 40.9x | 8 |
 FORRForrester Research, Inc. | $171M | $8.83 | — | — | Hold | 11.1x | 4 |
 ICFIICF International, Inc. | $1.4B | $79.68 | $110.00 | +38.1% | Buy | 11.2x | 13 |
 MCOMoody's Corporation | $87.6B | $505.67 | $536.44 | +6.1% | Buy | 30.1x | 32 |
 VRSKVerisk Analytics, Inc. | $26.6B | $204.59 | $222.86 | +8.9% | Hold | 26.5x | 25 |
 CSGPCoStar Group, Inc. | $12.4B | $30.55 | $35.44 | +16.0% | Buy | 21.9x | 27 |
 ACNAccenture plc | $159.4B | $260.50 | $230.05 | -11.7% | Buy | 18.8x | 53 |
 BAHBooz Allen Hamilton Holding Corporation | $10.3B | $85.35 | $92.00 | +7.8% | Buy | 14.0x | 23 |
Quick answers to the most common questions about buying CRAI stock.
Wall Street's consensus price target for CRAI is $194, -1.9% from its current price of $197.66. The below-market target from 1 analysts suggests limited near-term appreciation.
CRAI has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $194 implies -1.9% downside from current levels.
CRAI trades at a forward P/E of 23.9844x, representing a moderate valuation. With analysts targeting $194 (-1.9% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $194 for CRAI, while the most conservative target is $194. The consensus of $194 represents the median expectation. Our quantitative valuation model projects a bull case target of $325 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CRAI is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CRAI stock forecast based on 1 Wall Street analysts shows a consensus price target of $194, with estimates ranging from $194 (bear case) to $194 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $247, with bear/bull scenarios of $155/$325.
Our quantitative valuation model calculates CRAI's fair value at $247 (base case), with a bear case of $155 and bull case of $325. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.
CRAI trades at a forward P/E ratio of 24.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 24.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CRAI, with 0 Sell ratings and a price target of $194 (-1.9% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CRAI analyst price targets range from $194 to $194, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $194 consensus represents the middle ground. Our model's $155-$325 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.